VIable

Recommendations

Info

NDHI NAT IONAL DIALOGUE FOR Healthcare Innovation Propeller Health Partnership for COPD Adherence Organization Overview • Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies • The central concept of the company’s vision is to create value through innovation, with a focus on diseases with high unmet need Background Chronic obstructive pulmonary disease (COPD) is the 5 th most expensive chronic condition in the United States, costing the healthcare system over $56 billion annually. Many experts have estimated that digital health applications have the potential to generate $305 billion in savings across chronic disease care. Boehringer Ingelheim (BI) and Propeller Health believe that digital solutions can drive outcome-based medicine and reduce absolute consumer costs. The two companies have partnered to implement this model for COPD patients. By partnering with Propeller Health, BI is supporting two key elements of digital health: • Improved clinical analysis of COPD patients and self-management efforts outside of the office • Analysis of remotely stored health data to derive insights and develop algorithms to inform or improve patient health Collaboration Details The Propeller digital management platform will complement a COPD patient’s treatment experience with digital therapeutics and care management tools. The objectives of the program are to: • Enable healthcare providers to have visibility into their patients’ disease management patterns and to customize meaningful health interventions • Enhance patient outcomes by providing these services to patients and clinicians This first-in-kind commercial partnership between the biopharmaceutical industry and the digital health technology sector will test the following hypotheses about the Propeller platform: • The platform is accepted and adopted by COPD patients • Platform use increases adherence among COPD patients • The intervention is broadly supported among clinical staff and physicians BI has led healthcare collaboration efforts by introducing the program to stakeholders throughout the healthcare value chain, including integrated delivery networks, • Support patient engagement through a smart digital platform that educates patients about their symptoms • Increase medication adherence by helping patients develop a personalized disease management program An Initiative of the 13 | Propeller Health Partnership for COPD Adherence
NDHI NAT IONAL DIALOGUE FOR Healthcare Innovation academic medical centers, payer organizations, large medical groups, and pharmacy partners. The program began enrolling patients in August 2016, with a targeted enrollment of 2500 patients across 10-15 healthcare systems. Value Delivered As the program has just been initiated, no outcomes have been determined. However, the partners expect the program to add value through increased patient engagement, as well as enhanced patient and provider management of COPD. Path Forward In the short term, BI and Propeller Health are: • Continuing to enroll patients into the program • Developing an ROI model for this intervention that includes the indirect benefits of using digital platforms Current anti-kickback laws make these commercial programs difficult to scale, and BI believes that changes to these regulations may enhance the reach of these innovative care solutions. Despite these barriers, BI and Propeller Health maintain long term goals to scaling the program to additional healthcare systems. Propeller Health Partnership for COPD Adherence | 14
Page 1: VIable Solutions Private Sector Pro
Page 4 and 5: Contents Foreword .................
Page 6 and 7: Foreword The U.S. healthcare indust
Page 9 and 10: Section 1 Collaborations to Enable
Page 11 and 12: NDHI NAT IONAL DIALOGUE FOR Healthc
Page 17: NDHI NAT IONAL DIALOGUE FOR Healthc
Page 47: NDHI NAT IONAL DIALOGUE FOR Healthc
Page 68 and 69:
NDHI NAT IONAL DIALOGUE FOR Healthc
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93:
Page 96 and 97:
Page 99 and 100:
Section 3 Policy Reform to Shape th
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113:
Page 116:
show all

VIable

Create successful ePaper yourself

Delete template?

Save as template?